The latest portfolio update, growth stocks continue to excel despite a small September dip.

It's time for another portfolio update with continued positive results. The growth socks soar and my dividend stocks aren't doing too bad either!

Visiting my two M1 Finance portfolios and seeing how they have fared in the recent market turmoil.

[This March portfolio review about healthcare stocks may contain affiliate links for which I receive a commission at no cost to you. I only recommend products I use and trust.] Healthcare stocks were an ugly sector to be in this month. The reason? A bevy of democratic candidates talking up medicare for all. It’s easy to see why that would be bad for healthcare. After all, there’s a ton of parties making money from our current healthcare system. However, that may change if certain candidates have their way. Uncertainty is rarely good for stocks so we saw a big dip in a lot of big healthcare names this month. That…

[This February portfolio review may contain affiliate links for which I receive a commission at no cost to you. I only recommend products I use and trust.] The last month was a perfect example as to why it’s so hard to time the market. You never know when the stock market gains will return and missing them is a huge hit to your returns. It was easy to feel negative about the market after the shellacking it took in December. After all, look at the performance of my own portfolio and the S&P in the first 24 days of December. As always, the graphics below are from Personal Capital. That’s…